BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

Nordic Bioscience and Roche Launch Elecsys PRO-C3 Test to Advance Liver Fibrosis Assessment on cobas Analyzers

Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used w...

May 09, 2025 | News

Connext Completes Phase 1 for CNT201, Eyes Phase 2 Launch and Expansion into Peyronie’s Disease

Conducted under U.S. FDA-cleared IND– Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie's disease Connext, a clinical s...

May 09, 2025 | News

Aroa Biosurgery Surpasses 100 Peer-Reviewed Studies Validating AROA ECM Technology in Wound Care

Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed stud...

May 05, 2025 | Report

HistoIndex Raises S$9M to Accelerate AI-Powered Digital Pathology and Launch of FibroSIGHT™

HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) di...

May 02, 2025 | News

AstraZeneca and Qure.ai Hit 5 Million AI-Enabled Chest X-Rays Milestone Across LMICs

AstraZeneca, in partnership with health-tech company Qure.ai, announced the successful completion of 5 million artificial intelligence (AI) enabled chest X...

May 01, 2025 | News

Akeso’s Ivonescimab Outperforms Pembrolizumab in Phase III, Wins NMPA Approval for First-Line PD-L1-Positive NSCLC

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has re...

April 28, 2025 | News

Sanofi and Sobi Extend Lifesaving Commitment to WFH Humanitarian Aid Program with Up to 100 Million IUs of Factor Therapy Annually

Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistance The World Federat...

April 28, 2025 | News

SimonMed Partners with Lunit to Advance AI-Powered Breast Cancer Detection Across the U.S.

SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce thei...

April 24, 2025 | News

Roche Survey Calls for Immediate Action as Asia Pacific Faces Worsening Vision Health Crisis

Asia Pacific bears nearly two-thirds of the global burden of moderate-to-severe vision impairment. Although 90 percent of vision impairment is preventable ...

April 24, 2025 | News

Transverse Medical Completes First Patient Series in Feasibility Study of POINT-GUARD™ CEP Device in Australia

Transverse Medical Inc. is excited to announce the completion of the first series of patients under its Feasibility Clinical Study at the prestigious Victo...

April 22, 2025 | News

Eisai and Biogen’s Leqembi® Secures First-of-Its-Kind EU Authorization for Early Alzheimer’s

Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (...

April 21, 2025 | News

China Rises as Global Force in Blood Purification Tech at BPPC Annual Conference

Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, Hunan, for its annual c...

April 21, 2025 | News

Akeso Secures NMPA Approval for Ebdarokimab in Moderate-to-Severe Plaque Psoriasis

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, ...

April 21, 2025 | News

Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics

Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...

April 18, 2025 | News

Stay Connected